Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-16-011107
Filing Date
2016-02-16
Accepted
2016-02-16 16:06:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7044272_sc13g-a2.htm SC 13G/A 107468
  Complete submission text file 0000919574-16-011107.txt   109198
Mailing Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019
Business Address 157 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 212-333-0100
KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) CIK: 0001000097 (see all company filings)

IRS No.: 134015739 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-87649 | Film No.: 161428056
SIC: 2836 Biological Products, (No Diagnostic Substances)